CClinicalTrials.gg
CompletedNCT03784742REBOC2Updated Apr 12, 2024

Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Function

An interventional study of Nitrate rich beetroot juice and Placebo beetroot juice in No Dental Disease and Non-smoking, sponsored by University of Reading. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-12.

Sponsored by University of Reading · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

Diseases of the heart and blood vessels, including raised blood pressure, are one of the leading causes of death worldwide. Higher intakes of dietary nitrate, found abundantly in root vegetables such as beetroot, have been shown to have health benefits including lowering blood pressure and improving the elasticity of blood vessels. Bacteria which reside in the mouth and those in the gastrointestinal tract play an important role in converting dietary nitrate to nitrite and nitric oxide (a chemical which promotes the relaxation of blood vessels). In particular, removal of oral bacteria by using antiseptic mouthwash is accompanied by an increase in blood pressure in subjects with normal blood pressure, even after consuming nitrate-rich foods. To date, very little is known about the role of these oral bacteria in the control of blood pressure, and if there are any differences in bacterial composition between individuals.

Read the detailed description

Interested volunteers will be provided with an outline of the study and asked to complete a medical and lifestyle questionnaire (in person, by email or over the phone). Potentially suitable participants will be identified and asked to attend a screening session after a 12 h overnight fast (not eating during this time and only drinking water) during which the study will be explained in more detail before a consent form is signed. Anthropometric measurements will then be taken including weight, height and blood pressure. A 9 ml blood sample will also be collected on site at the Department of Food and Nutritional Sciences (Hugh Sinclair Unit of Human Nutrition). Subjects who meet the initial inclusion criteria will be invited to a further screening session during which time a dentist will check for dental diseases (e.g. current dental cavities or periodontal infection) and saliva flow rate. Volunteers without periodontal disease and with normal saliva flow will then be invited to participate in the study.

Eligible subjects will then be randomised to one of two treatments: i) up to 70 ml (the amount given will be equivalent to 3.7 mg/kg body weight) beetroot juice (James White Drinks Limited, UK) or ii) a matched volume of placebo beetroot juice (control, James White Drinks Limited, UK) to be consumed daily for 8 weeks. As drinking water is a major source of dietary nitrate, subjects will be provided with a water filter to reduce the nitrate level in their tap water for drinking and cooking during the study period. There will be a wash out period of 4 weeks between the intervention juices. In total, volunteers will be involved in the study for 20 weeks (five months).

On the day before each baseline study visit (weeks 0 and 12), volunteers will be required to fast overnight after having a low nitrate evening meal and only drinking low nitrate mineral water (Buxton mineral water), which will be provided to them, during this time. They will refrain from strenuous exercise and alcohol. On the morning of the study visit, the volunteers will be asked not to brush their teeth before they come to the clinical unit for their study visit.

When they arrive in the fasted state, the participants will be asked to provide a spot urine sample and a stool sample. Body weight and composition will be measured using the Tanita weighing scale, saliva sample and an oral bacteria sample will be collected by swabbing the tongue with a cotton swab. Volunteers will be asked to lie down for 20 minutes prior to the measurement of blood pressure and pulse wave analysis (PWA) using the Mobil-O-Graph device followed by the assessment of microvascular reactivity using Laser Doppler Imaging with iontophoresis. A blood sample of 20 ml (equivalent to just over 1 tablespoon) will then be taken before a light breakfast is provided. Volunteers will then be given a toothbrush and toothpaste to brush their teeth and asked to complete an online food frequency questionnaire (EatwellUK).

During the four-week wash-out period between interventions, participants will be instructed to avoid any beetroot juice drinks and maintain their usual dietary and lifestyle habits.

02

Conditions studied

  • No Dental Disease
  • Non-smoking
03

In context

Stomatognathic Diseases

110 studies on the registry are indexed under Stomatognathic Diseases; 26 are open to participants now.

This study's enrollment of 28 is below the median of 59 across 86 interventional studies indexed under Stomatognathic Diseases.

Browse Stomatognathic Diseases studies →

Lead sponsor

University of Reading is the lead sponsor of 146 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Male and female;

  • A signed consent form;
  • Blood pressure \<140/90 mm Hg;
  • BMI range 18.5 - 39.9 kg/m2;
  • Age 18-64 years;
  • Non-smoking;
  • Not taking blood pressure lowering medication or using medications known to influence vascular function such as a glyceryl trinitrate (GTN) spray;
  • No recent (within 3 months) or current use of antibiotics.

Exclusion criteria

Exclusion criteria are:

Diagnosed with a chronic illness;

  • Anaemia defined as a haemoglobin \< 115 g/l for women and \<130 g/l for men;
  • Individuals with food allergies or allergies to medicated mouthwash or ingredients in the oral products;
  • Requirements to take long-term medication active on the oral cavity including prebiotics and probiotics or have taken antibiotics within the last 3 months;
  • Gingivitis diagnosis, or periodontal disease or chronic oral complaints or existing oral pathology.
  • Less than four natural (enamel) buccal surfaces of upper molars available;
  • Presence of fixed or removable oral appliances (e.g., dentures, orthodontic wires); xerostomia (a persistent dry mouth) diagnosis;
  • Current smoker;
  • Already participating in a dietary intervention study or clinical trial;
  • Excessive alcohol consumption (> 14 units/wk);
  • Females who are pregnant or lactating;
  • Individuals not willing to give up using mouthwash or change their dental hygiene routine. Regular consumption or use of xylitol-based products such as toothpaste and chewing gum.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
28 participants (actual)

Study arms

  • Active comparator
    Nitrate-rich Beetroot juice

    Nitrate-rich beetroot juice equivalent to 3.7 mg nitrate per kg body weight daily for 8 weeks.

    Other: Nitrate rich beetroot juice

  • Placebo comparator
    Placebo beetroot juice

    Placebo beetroot juice (equivalent volume to the amount of nitrate-rich beetroot juice consumed) daily for 8 weeks.

    Other: Placebo beetroot juice

Interventions

  • OtherNitrate rich beetroot juice

    James White Drinks Limited beetroot juice (0.4-0.45 g nitrate/70 ml drink).

  • OtherPlacebo beetroot juice

    James White Drinks Limited Placebo beetroot juice (0 nitrate/70 ml drink).

06

What researchers measure

Primary outcomes

  1. Change in blood pressure measure

    Systolic blood pressure, diastolic blood pressure and pulse pressure

    Time frame: Before and after each 8 week intervention

  2. Change in oral bacteria composition

    Oral bacteria composition determined using next generation sequencing.

    Time frame: Before and after each 8 week intervention

Secondary outcomes

  1. Change in vascular reactivity

    Laser Doppler Imaging with iontophoresis.

    Time frame: Before and after each 8 week intervention

  2. Change in Nox concentrations in serum, urine and saliva

    Nitrate and nitrite concentrations will be determined using high performance liquid chromatography in plasma, urine and saliva. Nitric oxide will be calculated as the sum of nitrate and nitrite concentrations. Creatinine will be measured in the urine samples to normalise the nitrate and nitrite concentrations in urine for hydration status.

    Time frame: Before and after each 8 week intervention

  3. Change in gut bacteria composition

    Stool sample will be analysed to determine composition using next generation sequencing will be used to find the differences between treatments.

    Time frame: Before and after each 8 week intervention

  4. Change in fasting lipid profile

    Total cholesterol, HDL-C, and triacylglycerol will be measured using a clinical chemistry analyser. LDL-C will be calculated using the Friedewald formula.

    Time frame: Before and after each 8 week intervention

  5. Change in C-reactive protein

    C-reactive protein will be measured using a clinical chemistry analyser

    Time frame: Before and after each 8 week intervention

  6. Change in endothelial function

    Pulse wave analysis will be measured using Mobil-O-Graph

    Time frame: Before and after each 8 week intervention

  7. Change in body weight

    Body weight will be measured using a Tanita scale

    Time frame: Before and after each 8 week intervention

  8. Height measurement

    Height will be measured using a stadiometer

    Time frame: Before the intervention

  9. Change in body mass index

    Body mass index will be calculated from the body weight and height measurement

    Time frame: Before and after each 8 week intervention

  10. Change in insulin

    Insulin levels will be measured by ELISA

    Time frame: Before and after each 8 week intervention

  11. Change in glucose

    Glucose levels will be measured using a clinical chemistry analyser

    Time frame: Before and after each 8 week intervention

  12. Change in insulin sensitivity

    Glucose and insulin measurements will be used to calculate the homeostatic model assessment of insulin resistance (HOMA-IR)

    Time frame: Before and after each 8 week intervention

07

Study locations

1 site
  • Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading
    Reading, Berkshire RG6 6AP, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03784742
Lead sponsor
University of Reading
Collaborators
Saudi Cultural Bureau
Responsible party
Julie Lovegrove (Professor of Human Nutrition, Head of the Hugh Sinclair Unit of Human Nutrition, University of Reading) — Principal investigator
First posted
Dec 24, 2018
Start date
Dec 1, 2018
Primary completion
Dec 1, 2020
Completion
Dec 1, 2021
Last update
Apr 12, 2024

Study contacts

Julie A Lovegrove, BSc, PhD
principal investigator · University of Reading

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion